Search Results for “aging” – Page 93 – media

Remote Patient Monitoring Startup could Spell Major Turning Point in Digital Health

Ambient Clinical Analytics, the remote patient monitoring firm which became independent from Mayo Clinic in 2013, has elevated $1.5 million in a round led by Noaber Ventures. Noaber Ventures is the extended investment arm of Noaber Foundation and the company’s first European investor. The already existing investors such as Mayo Clinic, Bluestem Capital and Social Capital have also contributed to the round.
- Source: MobiHealthNews
- 704
- June 22, 2018
Company Insight digital health EHR
FDA Approval for AI Enabled Diabetes Software

The Food and Drug Administration (FDA) has granted approval for a request made by DreaMed regarding their artificial intelligence-enabled diabetic software, which is exclusively meant for the providers, who are managing Type 1 diabetes patients.
- Source: MobiHealthNews
- 858
- June 20, 2018
AI digital health FDA New Approvals type 1 diabetes
Eye Movements Analysis for Parkinson’s Disease

A new robotic system called OSCANN Desk has been developed by researchers at Spain’s Universidad Politécnica de Madrid (UPM) and start-up AURA Innotive Robotics. The system has been designed for the accurate analysis of eye movements in order to detect neurodegenerative diseases such as Parkinson’s disease.
- Source: Verdict Medical Devices
- 672
- June 19, 2018
digital health machine learning New Approvals Parkinson’s disease
Patient Capital Program for Start-ups of £2.5 Billion Created by U.K.

In an innovative push to help biotech start-ups in Britain become independent medium-sized enterprises, the U.K. set up a £2.5 billion patient capital program.
- Source: Fierce Biotech
- 698
- June 15, 2018
biotech digital health Market Views start ups
Selfie App to Prevent Skin Cancer

The mobile app named Sunface is available for both iPhones and Android-based devices. With the app, the user takes a selfie and is then offered three categories named ‘daily sun protection’, ‘no sun protection’ and ‘weekly sunbed’.
- Source: mHealthSpot
- 652
- June 14, 2018
mHealth Researches skin cancer
Consumers’ Favourite for Sending Healthcare Data is Secure Texting

According to 94% of physicians and 90% of hospitals in the survey, reports suggest that mobile technology in the healthcare sector is enhancing patients' safety and results. On the other hand, 63% reported ongoing challenges with a buy-in of general mobile adoption strategies and related enterprise technology execution
- Source: HealthIT Security
- 677
- June 13, 2018
cybersecurity digital health health IT Market Views
Wasdell Half-Million Investment For Lab Expansion

The UK Based, Wasdell Group a leading service provider for the pharma and medical industries, is planning to invest $671,000 to support its pharma manufacturing through a laboratory project; before the end of this year, the company is also planning to move into sterile manufacturing.
- Source: Fierce Pharma
- 1,099
- June 11, 2018
Company Insight pharmaceutical
PSYCHEDELICS – The potential anti-violence drug

"Although use of certain drugs like alcohol, methamphetamine or cocaine is associated with increased aggression and partner violence, use of psychedelics appears to have the opposite effect; we found that among men who have used psychedelics one or more times, the odds of engaging in partner violence was reduced by roughly half. That's significant."
- Source: Ddu
- 467
- June 11, 2018
Psychedelic drugs Researches
iBeat Raises Investment for its Continuous Monitor mHealth Wearable; Heart Watch

San Francisco-based company iBeat, an mHealth wearable development company has announced new funding from form SCOR Life & Transamerica Ventures and Health Ventures for its mHealth devices, Heart Watch which continuously monitors the heart.. iBeat did not state what the total amount was, only that the investments round was “upward of seven figures”.
- Source: MobiHealthNews
- 974
- June 8, 2018
Company Insight mHealth wearables
Therapy Against Progeria

After conducting a clinical trial study at Boston Children’s Hospital, scientists from Brown University recommended that a lonafarnib therapy could increase the survival rate of progeria patients. But the mode of action of lonafarnib is still uncertain.
- Source: Ddu
- 533
- June 7, 2018
progeria rare diseases Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.